Mangalam Drugs & Organics Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mangalam Drugs & Organics Limited with three other
companies in this sector in India:
sales of 2.71 billion Indian Rupees [US$36.45 million]
Gufic Biosciences Ltd
(3.01 billion Indian Rupees [US$40.54 million]
of which 95%
was Pharma), and
Lasa Supergenerics Ltd
(2.44 billion Indian Rupees [US$32.80 million]
Mangalam Drugs & Organics Limited reported sales of 2.79 billion Indian Rupees (US$37.63 million)
March of 2018.
decrease of 7.8%
versus 2017, when the company's sales were 3.03 billion Indian Rupees.